Log In

Biomarkers in cancer immunotherapy

Files

biomarkers.pdf (632.2 KB)

Publication date

2015-01-12

Authors

Schumacher, Ton N
Keşmir, CanISNI 0000000419420486
van Buuren, Marit MISNI 0000000419517413

Editors

Advisors

Supervisors

DOI

https://doi.org/10.1016/j.ccell.2014.12.004

Document Type

Article

Metadata

Show full item record

Collections

Utrecht University Repository
Open Access logo

License

taverne

Abstract

Antibodies against T cell checkpoint molecules have started to revolutionize cancer treatment. Nevertheless, less than half of all patients respond to these immunotherapies. Recent work supports the potential value of biomarkers that predict therapy outcome and inspires the development of assay systems that interrogate other aspects of the cancer-immunity cycle.

Keywords

Taverne, SDG 3 - Good Health and Well-being

Citation

Schumacher, T N, Kesmir, C & van Buuren, M M 2015, 'Biomarkers in cancer immunotherapy', Cancer Cell, vol. 27, no. 1, pp. 12-14. https://doi.org/10.1016/j.ccell.2014.12.004

URI

http://hdl.handle.net/1874/320977